TGF-beta1, IL-10 and IL-4 in colostrum of allergic and nonallergic mothers

• Autorzy: Marek A. , Zagierski M. , Liberek A. , Aleksandrowicz E. , Korzon M. , Krzykowski G. , Kaminska B. , Szlagatys-Sidorkiewicz A.
• Języki publikacji: EN

Abstrakty

EN

Objective: To determine transforming growth factor (TGF) β1, interleukin (IL) 4, and IL-10 concentrations in human milk and to assess the relationship between allergic disorders in mothers and the content of the interleukins in their milk. Material and methods: Thirty allergic and 46 healthy mothers were included in the study. Colostrum was collected 2-3 days after delivery. Cytokine concentrations were determined with commercial enzyme-linked immunosorbent systems. Results: TGF-β1was found in milk from 23 women in the control group (53.49%) and 11 in the allergy group (37.93%). When TGF-β1 was present, the median concentration was higher in the allergy group than in the control (61.5 and 30.4 pg/mL, respectively; P < 0.004). IL-10 was present in the colostrum of all the women and the median IL-10 concentration did not differ between the allergy (50.5 pg/mL) and control (51.5 pg/mL) groups. The probability of occurrence of a positive IL-4 value in the allergy group was greater than in the control group (chi-squared [df = 1] = 2.60, P < 0.053). Median IL-4 level did not differ significantly between the two groups (0.5 and 0.5 pg/mL respectively). Conclusions: TGF-β1 was detected less often in the colostrum of allergic mothers than in that of mothers without allergy (but the difference was not statistically significant). IL-4 was found more often in the colostrum of allergic mothers than nonallergic ones. The allergy status did not correlate with IL-10 concentration.

Słowa kluczowe

PL

interleukin 4; interleukin 10; transforming growth factor-beta 1; human milk; allergy; interleukin content; allergic disorder; mother; allergic mother; non-allergic mother; colostrum; relationship

• Wydawca: -
• Czasopismo: Acta Biochimica Polonica
• Rocznik: 2009
• Tom: 56
• Numer: 3
• Opis fizyczny: p.411-414,ref.

Twórcy

autor

Marek A.

• Medical University of Gdansk, Nowe Ogrody 1-6, 80-803 Gdansk, Poland

autor

Zagierski M.

autor

Liberek A.

autor

Aleksandrowicz E.

autor

Korzon M.

autor

Krzykowski G.

autor

Kaminska B.

autor

Szlagatys-Sidorkiewicz A.

Bibliografia

• Beyer K, Castro R, Birnbaum A, Benkov K, Pittman N, Sampson HA (2002) Human milk-specific mucosal lymphocytes of the gastrointestinal tract display a TH2 cytokine profile. J Allergy Clin Immunol 109: 707-713. 
• Böttcher MF, Jenmalm MC, Garofalo RP, Björkstén B (2000) Cytokines in breast milk from allergic and nonallergic mothers. Pediatr Res 47: 157-162. 
• Böttcher MF, Jenmalm MC, Björkstén B (2003) Cytokine, chemokine and secretory IgA levels in human milk in relation to atopic disease and IgA production in infants. Pediatr Allergy Immunol 14: 35-41. 
• Field CJ (2005) The immunological components of human milk and their effect on immune development in infants. J Nutr 135: 1-4. 
• Friedman NJ, Zeiger RS (2005) The role of breast-feeding in the development of allergies and asthma. J Allergy Clin Immunol 115: 1238-1248. 
• Garofalo R, Chheda S, Mei F, Palkowetz KH, Rudloff HE, Schmalstieg FC, Rassi DK, Goldman AS (1995) Interleukin-10 in human milk. Pediat Res 37: 444-449. 
• Goldman AS (1993) The immune system of human milk: Antimicrobial, antiinflammatory and immunomodulating properties. Pediatr Infect Dis J 12: 664-671. 
• Hanson L, Silfvedral SA, Stromback L, Erling V, Zaman S, Olcen P, Telemo E (2001) The immunological role of breast feeding. Pediatr Allergy Immunol (Suppl) 12: 15-19. 
• Hanson LA, Korotkova M, Telemo E (2003) Breast-feeding, infant formulas, and the immune system. Ann Allergy Asthma Immunol 90 (Suppl): 59-63. 
• Hawkes JS, Bryan DL, Gibson RA (2002) Variations in transforming growth factor beta in human milk are not related to levels in plasma. Cytokine 17: 182-186. 
• Kalliomäki M, Ouwehand A, Arvilommi H, Kero P, Isolauri E (1999) Transforming growth factor-β in breast milk: A potential regulator of atopic disease at an early age. J Allergy Clin Immunol 104: 1251-1257. 
• Kelly D, Coutts AGP (2000) Early nutrition and the development of immune function in the neonate. Proc Nutr Soc 59: 177-185. 
• Laiho K, Lampi A, Hämäläinen M, Moilanen E, Piironen V, Arvola T, Syrjanen S, Isolauri E (2003) Breast milk fatty acids, eicosanoids, and cytokines in mothers with and without allergic disease. Pediatr Res 53: 642-647. 
• Meki A-R MA, Saleem TA, Al-Ghazali MH, Sayed AA (2003) Interleukins-6, -8 and -10 and tumor necrosis factor-alpha and its soluble receptor I in human milk at different periods of lactation. Nutr Res 23: 845-855.
• Newburg DS (2005) Innate immunity and human milk. J Nutr 135: 1308-1312. 
• Rigotti E, Piacentini GL, Ress M, Pigozzi R, Boner AL, Peroni DG (2006) Transforming growth factor-beta and interleukin-10 in breast milk and development of atopic diseases in infants. Clin Exp Allergy 36: 614-618. 
• Saarinen KM, Juntunen-Backman K, Järvenpää AL, Klemetti P, Kuitunen P, Lope L, Renlund M, Siivola M, Vaarala O, Savilahti E (2000) Breast-feeding and the development of cows' milk protein allergy. Adv Exp Med Biol 478: 121-130. 
• Snijders BEP, Damoiseaux JGMC, Penders J, Kummeling I, Stelma FF, van Ree R, van den Brandt PA, Thijs C (2006) Cytokines and soluble CD14 in breast milk in relation with atopic manifestations in mother and infant (KOALA study). Clin Exp Allergy 36: 1609-1615. 
• Zwiebel JA, Bano M, Nexo E, Salomon DS, Kidwell WR (1986) Partial purification of transforming growth factors from human milk. Cancer Res 46: 933-939.